Advertisement

Topics

GSK grabs Roche veteran and Calico scientist Barron as new R&D head

12:03 EST 8 Nov 2017 | Reuters

LONDON (Reuters) - GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief Executive Emma Walmsley steps up her drive to improve productivity.

Original Article: GSK grabs Roche veteran and Calico scientist Barron as new R&D head

NEXT ARTICLE

More From BioPortfolio on "GSK grabs Roche veteran and Calico scientist Barron as new R&D head"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...